Anecortave Acetate Risk-Reduction Trial (AART)
NCT00307398
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2596
Enrollment
INDUSTRY
Sponsor class
Stopped
Management decision
Conditions
Dry AMD
Interventions
DRUG:
Anecortave Acetate (AL-3789) sterile suspension, 15 mg or 30 mg
OTHER:
Anecortave Acetate Vehicle
Sponsor
Alcon Research